InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 332003

Tuesday, 10/08/2019 8:34:23 AM

Tuesday, October 08, 2019 8:34:23 AM

Post# of 345969

"Phosphatidylserine(PS) is a newly discovered GPR174 agonist."

"Represents a new axis in cancer Immunotherapy for all solid tumors"

"Could address non-responders to all current therapies"

READ all 51 pages of Corportate Presentation and PS is STRESSED as high importance and BLA filed / Breakthru Designation already accepted ....says NO MORE patients required / BLA data significant



Avid Bioservices CDMO announcement this morning with official expansion for advanced service manufacturing etc and helps client onboarding ...

This is massive, especially since PS Targeting / receptors gave Peregrine and many other biotech a KEY to knowing the protein pathways changes required

Omeros has officially opened another door and execs at Omeros having Eli Lilly ties in coordination with Oncologie Inc Eli Lilly ties...some investors and IIS are quietly accumulating till it is official with FDA approval based upon PS Targeting ...and Avid?

That is why the manufacturing had been expanded for the new client - top 10 revenue Big Pharma, which has not been disclosed yet for that name

BTD awarded and BLA filed for Omeros, that had a PS Targeting pipeline that (if prior post link read, needs no more patient data for BLA )

Looks like John Springs Stafford ties, has an extended reach into Zach where they failed to tell investors that there is a big buyout looming because why would Roche just sit back and do nothing ?

Very interesting times and read the Omeros report...no wonder why Peregrine had to move PS Targeting approvals into FDA hands via a very non conventional manner ...due to multiple sabotage attempts first seen in an eye opening case Peregrine vs CSM Clinical Supplies Management with Jeanette Bleecker admitting in deposition filings and CEO Gerald Finken ex BMS and BMS had Opdivo pending at this 2012 timeframe and PS Targeting would have siderailed Opdivo

Some IIS have some extra information that had not been made public but why would Avid Bioservices BOD be hiding it? Or maybe it is legal since they say Oncologie Inc is front running things ...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News